These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study. Ferguson JJ; Antman EM; Bates ER; Cohen M; Every NR; Harrington RA; Pepine CJ; Theroux P; Am Heart J; 2003 Oct; 146(4):628-34. PubMed ID: 14564315 [TBL] [Abstract][Full Text] [Related]
9. Anticoagulants in acute coronary syndromes. Turpie AG Am J Cardiol; 1999 Sep; 84(5A):2M-6M. PubMed ID: 10505536 [TBL] [Abstract][Full Text] [Related]
10. Low-molecular-weight heparins in the management of acute coronary syndromes. Zed PJ; Tisdale JE; Borzak S Arch Intern Med; 1999 Sep; 159(16):1849-57. PubMed ID: 10493315 [TBL] [Abstract][Full Text] [Related]
12. The role of low-molecular-weight heparins in the management of unstable angina and non-ST-segment elevation myocardial infarction. Cohen M J Thromb Thrombolysis; 2001 Apr; 11(2):171-4. PubMed ID: 11406733 [No Abstract] [Full Text] [Related]
13. Enoxaparin in unstable angina patients who would have been excluded from randomized pivotal trials. Collet JP; Montalescot G; Fine E; Golmard JL; Dalby M; Choussat R; Ankri A; Dumaine R; Lesty C; Vignolles N; Thomas D J Am Coll Cardiol; 2003 Jan; 41(1):8-14. PubMed ID: 12570937 [TBL] [Abstract][Full Text] [Related]
15. Antithrombotic therapy in acute coronary syndromes: key notes from ESSENCE and TIMI 11B. Fox KA Semin Hematol; 2001 Apr; 38(2 Suppl 5):67-74. PubMed ID: 11449345 [TBL] [Abstract][Full Text] [Related]
16. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F N Engl J Med; 1997 Aug; 337(7):447-52. PubMed ID: 9250846 [TBL] [Abstract][Full Text] [Related]
17. Management of acute coronary syndromes with low molecular weight heparin: TIMI 11A and 11B. Turpie AG Can J Cardiol; 1998 Aug; 14 Suppl E():20E-23E. PubMed ID: 9779029 [TBL] [Abstract][Full Text] [Related]
18. [Low-molecular weight heparin and acute coronary syndrome: theoretical background and its use in clinical practice]. Ottani F; Ferrini D; Di Pasquale G; Galvani M Ital Heart J Suppl; 2001 Sep; 2(9):958-71. PubMed ID: 11675833 [TBL] [Abstract][Full Text] [Related]
19. Costs and cost effectiveness of low molecular weight heparins and platelet glycoprotein IIb/IIIa inhibitors: in the management of acute coronary syndromes. Bosanquet N; Jönsson B; Fox KA Pharmacoeconomics; 2003; 21(16):1135-52. PubMed ID: 14594436 [TBL] [Abstract][Full Text] [Related]